C25H44N14O7.C25H44N14O8
Neat
652.72 668.72
Capostatin; Capreomicin; Capreomicina; Capreomycine; Capromycin; Capreomycin Complex; RefChem:123292; CHEBI:3371; DTXSID8040989; J04AB30; (3S)-3, 6-diamino-N-(((2S, 5S, 8E, 11S, 15S)-15-amino-11-((6R)-2-amino-1, 4, 5, 6-tetrahydropyrimidin-6-yl)-8-((carbamoylamino)methylidene)-2-(hydroxymethyl)-3, 6, 9, 12, 16-pentaoxo-1, 4, 7, 10, 13-pentazacyclohexadec-5-yl)methyl)hexanamide;(3S)-3, 6-diamino-N-(((2S, 5S, 8E, 11S, 15S)-15-amino-11-((6R)-2-amino-1, 4, 5, 6-tetrahydropyrimidin-6-yl)-8-((carbamoylamino)methylidene)-2-methyl-3, 6, 9, 12, 16-pentaoxo-1, 4, 7, 10 and 13-pentazacyclohexadec-5-yl)methyl)hexanamide; 11003-38-6; 232HYX66HC; Capastat; capreomycin; Capreomycinum; Kapreomycin; SCHEMBL3666; Q415909
(3S)-3, 6-diamino-N-[[(2S, 5S, 8E, 11S, 15S)-15-amino-11-[(6R)-2-amino-1, 4, 5, 6-tetrahydropyrimidin-6-yl]-8-[(carbamoylamino)methylidene]-2-(hydroxymethyl)-3, 6, 9, 12, 16-pentaoxo-1, 4, 7, 10, 13-pentazacyclohexadec-5-yl]methyl]hexanamide;(3S)-3, 6-diamino-N-[[(2S, 5S, 8E, 11S, 15S)-15-amino-11-[(6R)-2-amino-1, 4, 5, 6-tetrahydropyrimidin-6-yl]-8-[(carbamoylamino)methylidene]-2-methyl-3, 6, 9, 12, 16-pentaoxo-1, 4, 7, 10 and 13-pentazacyclohexadec-5-yl]methyl]hexanamide
InChI=1S/C25H44N14O8.C25H44N14O7/c26-4-1-2-11(27)6-17(41)32-8-14-20(43)35-15(9-34-25(30)47)21(44)39-18(13-3-5-31-24(29)38-13)23(46)33-7-12(28)19(42)37-16(10-40)22(45)36-14;1-11-19(41)36-15(9-32-17(40)7-12(27)3-2-5-26)21(43)37-16(10-34-25(30)46)22(44)39-18(14-4-6-31-24(29)38-14)23(45)33-8-13(28)20(42)35-11/h9,11-14,16,18,40H,1-8,10,26-28H2,(H,32,41)(H,33,46)(H,35,43)(H,36,45)(H,37,42)(H,39,44)(H3,29,31,38)(H3,30,34,47);10-15,18H,2-9,26-28H2,1H3,(H,32,40)(H,33,45)(H,35,42)(H,36,41)(H,37,43)(H,39,44)(H3,29,31,38)(H3,30,34,46)/b15-9+;16-10+/t11-,12-,13+,14-,16-,18-;11-,12-,13-,14+,15-,18-/m00/s1